471
Journals
1.6M
Articles
38.7M
Citations
291.7K
Authors

Most Cited Articles of Oncology in 2021

TitleJournalYearCitations
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesCa-A Cancer Journal for Clinicians202111.2K
Cancer Statistics, 2021Ca-A Cancer Journal for Clinicians20214K
The 2021 WHO Classification of Tumors of the Central Nervous System: a summaryNeuro-Oncology2021708
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodiesCell Host and Microbe2021569
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody RecognitionCell Host and Microbe2021525
Cancer statistics for the year 2020: An overviewInternational Journal of Cancer2021493
Japanese gastric cancer treatment guidelines 2018 (5th edition)Gastric Cancer2021484
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralizationCell Host and Microbe2021423
Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communicationsLancet Regional Health - Europe, The2021284
RNA in cancerNature Reviews Cancer2021279
Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralizationCell Host and Microbe2021277
Broadening horizons: the role of ferroptosis in cancerNature Reviews Clinical Oncology2021272
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trialLancet Oncology, The2021244
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational studyLancet Oncology, The2021240
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccinesCell Host and Microbe2021225
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersiteCell Host and Microbe2021215
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthoodNature Reviews Clinical Oncology2021204
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinomaInternational Journal of Gynecological Cancer2021203
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to NeutralizationCell Host and Microbe2021198
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trialLancet Oncology, The2021180
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021Journal of the National Comprehensive Cancer Network: JNCCN2021177
The variant gambit: COVID-19's next moveCell Host and Microbe2021164
Exploring the NK cell platform for cancer immunotherapyNature Reviews Clinical Oncology2021161
High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer typesAnnals of Oncology2021158
Liquid biopsy enters the clinic - implementation issues and future challengesNature Reviews Clinical Oncology2021158